Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

ABSTRACT: The goal of this laboratory research is to look for genetic and epigenetic markers that can predict which patients with stage III colorectal cancer will benefit from fluorouracil-based adjuvant chemotherapy.

DISEASE(S): Stage Iii Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2242379 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR